1. Home
  2. ATOM vs KALA Comparison

ATOM vs KALA Comparison

Compare ATOM & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atomera Incorporated

ATOM

Atomera Incorporated

HOLD

Current Price

$8.81

Market Cap

189.2M

Sector

Technology

ML Signal

HOLD

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.14

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATOM
KALA
Founded
2001
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.2M
172.0M
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
ATOM
KALA
Price
$8.81
$0.14
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$31.50
AVG Volume (30 Days)
2.2M
2.9M
Earning Date
05-05-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
4.41
67.39
EPS
N/A
N/A
Revenue
$62,000.00
N/A
Revenue This Year
$527.69
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.89
$0.14
52 Week High
$9.59
$20.58

Technical Indicators

Market Signals
Indicator
ATOM
KALA
Relative Strength Index (RSI) 79.31 29.58
Support Level $2.20 N/A
Resistance Level N/A $0.24
Average True Range (ATR) 0.76 0.02
MACD 0.32 0.00
Stochastic Oscillator 84.13 2.06

Price Performance

Historical Comparison
ATOM
KALA

About ATOM Atomera Incorporated

Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used in the semiconductor industry. The company's silicon technology can be used for applications like Analog, DRAM, logic, processors, and SRAM. Geographically, it generates maximum revenue from North America.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: